Hormone Therapy Insights
Peter discusses the misleading nature of relative risk statistics in hormone replacement therapy, emphasizing the importance of understanding absolute risk. He highlights the potential benefits of bioidentical hormones for women going through menopause, while also addressing the role of synthetic progesterone in breast cancer risk. Additionally, the conversation touches on the safety of topical estrogen compared to oral forms and the significance of genetic factors in clotting disorders.In this clip
From this podcast
Huberman Lab
Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85
Related Questions
Do estrogen therapies increase the risk of cancer as discussed in the episode Dr. Peter Attia on Mastering Longevity – Insights on Cancer Prevention, Heart Disease, and Aging and the clip Hormone Therapy Insights?
What are the detailed risks of menopausal hormone therapy (MHT) related to cancer as discussed in the episode Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85 and the clip Hormone Therapy Insights?
How does hormone replacement therapy (HRT) affect breast cancer risk based on the episode Episode 331: The Truth About Perimenopause with Dr. Arianna Sholes-Douglas and the clip Hormone Therapy Myths?